PROTEOSTASIS THERAPEUTICS, INC.·4

Feb 5, 8:05 PM ET

Zecevic Marija 4

4 · PROTEOSTASIS THERAPEUTICS, INC. · Filed Feb 5, 2019

Insider Transaction Report

Form 4
Period: 2019-02-01
Zecevic Marija
VP, Business Development
Transactions
  • Exercise/Conversion

    Common Stock

    2019-02-01+22,31322,313 total
  • Exercise/Conversion

    Restricted Stock Units

    2019-02-0122,3130 total
    Common Stock (22,313 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of PTI common stock.
  • [F2]The restricted stock units vested in full on February 1, 2019.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION